BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 19450592)

  • 1. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells.
    van der Flier LG; Haegebarth A; Stange DE; van de Wetering M; Clevers H
    Gastroenterology; 2009 Jul; 137(1):15-7. PubMed ID: 19450592
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of LGR5, an intestinal stem cell marker, during each stage of colorectal tumorigenesis.
    Takeda K; Kinoshita I; Shimizu Y; Matsuno Y; Shichinohe T; Dosaka-Akita H
    Anticancer Res; 2011 Jan; 31(1):263-70. PubMed ID: 21273608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer stem cells.
    Yeung TM; Mortensen NJ
    Dis Colon Rectum; 2009 Oct; 52(10):1788-96. PubMed ID: 19966616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ validation of an intestinal stem cell signature in colorectal cancer.
    Ziskin JL; Dunlap D; Yaylaoglu M; Fodor IK; Forrest WF; Patel R; Ge N; Hutchins GG; Pine JK; Quirke P; Koeppen H; Jubb AM
    Gut; 2013 Jul; 62(7):1012-23. PubMed ID: 22637696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell marker olfactomedin 4: critical appraisal of its characteristics and role in tumorigenesis.
    Grover PK; Hardingham JE; Cummins AG
    Cancer Metastasis Rev; 2010 Dec; 29(4):761-75. PubMed ID: 20878207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proliferation of cancer stem cells in colorectal adenocarcinoma].
    Raskin GA; Orlova RV; Petrov SV; Protasova AÉ; Pozharisskiĭ KM
    Vopr Onkol; 2014; 60(1):47-51. PubMed ID: 24772616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic relevance of granulocyte colony-stimulating factor in ovarian carcinomas.
    Münstedt K; Hackethal A; Eskef K; Hrgovic I; Franke FE
    Arch Gynecol Obstet; 2010 Sep; 282(3):301-5. PubMed ID: 20012635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The stem of cancer.
    Fodde R
    Cancer Cell; 2009 Feb; 15(2):87-9. PubMed ID: 19185843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter.
    Salnikov AV; Kusumawidjaja G; Rausch V; Bruns H; Gross W; Khamidjanov A; Ryschich E; Gebhard MM; Moldenhauer G; Büchler MW; Schemmer P; Herr I
    Cancer Lett; 2009 Mar; 275(2):185-93. PubMed ID: 19026485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver cancer stem cells: implications for a new therapeutic target.
    Lee TK; Castilho A; Ma S; Ng IO
    Liver Int; 2009 Aug; 29(7):955-65. PubMed ID: 19490415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
    Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
    Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research progression in colorectal cancer stem cells].
    Wu TY; Cui L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):297-300. PubMed ID: 23536355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of cells expressing OLFM4 and LGR5 mRNA by in situ hybridization in the yolk sac and small intestine of embryonic and early post-hatch chicks.
    Zhang H; Wong EA
    Poult Sci; 2018 Feb; 97(2):628-633. PubMed ID: 29155957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symmetric division of cancer stem cells--a key mechanism in tumor growth that should be targeted in future therapeutic approaches.
    Boman BM; Wicha MS; Fields JZ; Runquist OA
    Clin Pharmacol Ther; 2007 Jun; 81(6):893-8. PubMed ID: 17460605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advancement of studies on ALDH1 as a universal marker of stem cells].
    Han M; Wu C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Oct; 27(5):1183-6. PubMed ID: 21089696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, EMT nor metastatic spread in colorectal cancer.
    Jaitner S; Pretzsch E; Neumann J; Schäffauer A; Schiemann M; Angele M; Kumbrink J; Schwitalla S; Greten FR; Brandl L; Klauschen F; Horst D; Kirchner T; Jung A
    J Pathol Clin Res; 2023 Jan; 9(1):73-85. PubMed ID: 36349502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of intra-acinar necrosis as a marker of colorectal liver metastasis.
    Wong NA; Neville LP
    Histopathology; 2007 Nov; 51(5):725-7. PubMed ID: 17927604
    [No Abstract]   [Full Text] [Related]  

  • 18. CK20/CK7 protein expression in colorectal cancer: a marker for progression of colorectal cancer.
    Bressenot A; Zimmer O
    Hum Pathol; 2008 Nov; 39(11):1714; author reply 1715. PubMed ID: 19646396
    [No Abstract]   [Full Text] [Related]  

  • 19. Metastatic activity and chemotherapy resistance in human pancreatic cancer--influence of cancer stem cells.
    Ischenko I; Seeliger H; Jauch KW; Bruns CJ
    Surgery; 2009 Sep; 146(3):430-4. PubMed ID: 19715799
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of stem cells in small intestine and colon by marker gene Lgr5.
    Barker N; van Es JH; Kuipers J; Kujala P; van den Born M; Cozijnsen M; Haegebarth A; Korving J; Begthel H; Peters PJ; Clevers H
    Nature; 2007 Oct; 449(7165):1003-7. PubMed ID: 17934449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.